BENGALURU: The Karnataka High Court appointed the wife of a retired man as his guardian to operate his three savings bank ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in class IgG cleaving enzyme, in Guillain-Barré Syndrome ...

Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA), will present data from its 15-HMedIdeS-09 Phase 2 single arm study of imlifidase, a first in ...

The GBS | CIDP Foundation International is making strides to increase awareness of Guillain-Barré Syndrome (GBS), Chronic ...

First Oral Presentation by the International Guillain-Barré Syndrome Outcomes Study (IGOS) of the Real-World Evidence (RWE) Results Showing Improved Outcomes with Tanruprubart (formerly ANX005) Compar ...

To help you find the system that best fits your needs, we assessed costs, response times, ease of use, and then tested our top picks to see how they perform. Table of Contents Our rankings ...

The GBS | CIDP Foundation International is commemorating Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy Awareness Month this May by launching a global campaign to raise ...

What are Valorant ranks? We've taken a deep dive into the Valorant ranking system, to show you how they work, and what the current distribution is. Looking at these figures, we can glean all kinds ...

A rare autoimmune disorder that affects the peripheral nervous system, not only does GBS appear suddenly, its residual symptoms can last for years, if not decades. Even after 20 years, some 42% of ...

But GBS usually comes on days or weeks after you ... These medications bring down inflammation and slow the immune system. Immunotherapy. These drugs interrupt your immune system to help stop ...

After you accept our offer of admission, the GBS Finance Manager will send you an appointment letter formally outlining financial details. If you have questions about the appointment letter, contact ...

In an interview with AIM, John Dawber, corporate vice president and managing director of Novo Nordisk GBS, pointed out, “Seventeen years ago, when Novo Nordisk established its GCC, the motivation was ...